Preissner
Andrew M. Preissner, Suffield, CT US
Patent application number | Description | Published |
---|---|---|
20080199583 | Method for ensuring the use of brine with an optimal composition - A method of freezing with brine comprising releasing at least one ingredient in an effective amount from an automated device into the brine so that the brine is rendered unusable for its intended purpose, thereby ensuring that the brine is used only in a optimal composition. | 08-21-2008 |
Christian Preissner, Nuernberg DE
Patent application number | Description | Published |
---|---|---|
20100206264 | THROTTLE VALVE - Throttle valves often have the problem that the throttle must be precisely positioned with and fixed to the throttle shaft. In the throttle valve ( | 08-19-2010 |
Curt A. Preissner, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140055005 | MECHANICAL DESIGN OF DEFORMATION COMPENSATED FLEXURAL PIVOTS STRUCTURED FOR LINEAR NANOPOSITIONING STAGES - A method and deformation compensated flexural pivots structured for precision linear nanopositioning stages are provided. A deformation-compensated flexural linear guiding mechanism includes a basic parallel mechanism including a U-shaped member and a pair of parallel bars linked to respective pairs of I-link bars and each of the I-bars coupled by a respective pair of flexural pivots. The basic parallel mechanism includes substantially evenly distributed flexural pivots minimizing center shift dynamic errors. | 02-27-2014 |
20140259235 | SIMULTANEOUS TOPOGRAPHIC AND ELEMENTAL CHEMICAL AND MAGNETIC CONTRAST IN SCANNING TUNNELING MICROSCOPY - A method and system for performing simultaneous topographic and elemental chemical and magnetic contrast analysis in a scanning, tunneling microscope. The method and system also includes nanofabricated coaxial multilayer tips with a nanoscale conducting apex and a programmable in-situ nanomanipulator to fabricate these tips and also to rotate tips controllably. | 09-11-2014 |
Klaus Preissner, Giessen DE
Patent application number | Description | Published |
---|---|---|
20080317735 | Pharmaceutical preparation with RNA as hemostasis cofactor - Pharmaceutical preparations which comprise RNA or one or more coagulation-promoting fragments of RNA in amounts sufficient to promote coagulation and to promote fibrinolysis are described. They are in particular advantageously employed together with an activator for hemostatic processes such as factor VII-activating protease (FSAP) | 12-25-2008 |
20130095108 | FACTOR XII INHIBITORS FOR TREATING INTERSTITIAL LUNG DISEASE - The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment. | 04-18-2013 |
Klaus T. Preissner, Giessen DE
Patent application number | Description | Published |
---|---|---|
20080234189 | USE OF A COMPOSITION - A method of treatment of a mammal suffering from an inflammatory condition or a cancer includes administering an anti-inflammatory protein or a peptide fraction of the protein having at least one repeating unit, the protein being selected from a group of proteins designated Eap (Extracellular adherence protein). The inflammatory condition may be a non-bacterial or bacterial inflammation. | 09-25-2008 |
Klaus T. Preissner, Glessen DE
Patent application number | Description | Published |
---|---|---|
20090075893 | Inhibition of Angiogenesis by Neutrophil Alpha-Defensins - The present invention relates to the inhibition of angiogenesis by neutrophil alpha-defensins. Further, the present invention relates to methods involving the inhibition of endothelial cell adhesion to the extracellular matrix, endothelial cell apoptosis, and endothelial cell angiogenesis mediated by alpha-defensins. | 03-19-2009 |
Marcus Preissner, Vaihingen DE
Patent application number | Description | Published |
---|---|---|
20140018968 | Method for determining and/or controlling an operating time of a consumer coupled to a power station, in particular a photovoltaic power station, and to an energy storage device, and method for operating an energy storage device coupled to a power station - A device for determining an operating time of a consumer coupled to a power station and energy/storage device, having a first determining device to determine energy production from the station during a time, a second determining device to determine energy consumption of the consumer during a time, a third determining device to determine energy stored in the storage device for operating the consumer, and a prediction device to determine/display, considering the determined energy production, the determined stored energy, and the determined energy consumption, an operating time that the consumer is operatable by the energy from the station and by the stored energy, and/or having a control device to determine a consumer operating time and to adapt stored energy for operating the consumer, considering the determined energy production, the determined stored energy, and the determined energy consumption, the adaptation occurring so that the consumer is operatable for the operating time. | 01-16-2014 |
Olaf Preissner, Kirchheim Unter Teck. DE
Patent application number | Description | Published |
---|---|---|
20120120108 | NAVIGATION SYSTEM - A navigation system comprises a map memory, a processing device and a display. The processing unit is configured to simultaneously display a first portion of a map stored in the map memory using a first perspective and a second portion of the map using a second perspective different from the first perspective on the display. | 05-17-2012 |
Robert Preissner, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110251220 | Pharmaceutical compositions comprising gamma secretase modulators - The present invention relates to pharmaceutical compositions comprising gamma secretase modulators as well as to the use of gamma secretase modulators for treating renal disorders, cancer, neurodegenerative disorders as well as related disorders. | 10-13-2011 |